New TB Vaccines
Development of new vaccines to protect against and prevent tuberculosis is gaining substantial momentum. Encouraging and consistent scientific results from the laboratory and from early field trials indicate that introduction of new effective TB vaccines will be an essential component of any strategy to eliminate tuberculosis by 2050.
New TB vaccines to prevent childhood and adult forms of tuberculosis, to reduce tuberculosis in persons coinfected with HIV, and to shorten drug treatment regimens will fundamentally alter our approach to TB control.
By 2015, we will aim to make a new, safe, effective and affordable vaccine available. This new vaccine will have potential for a significant impact on TB control in later years.
The full implementation of the Global Plan's R&D activities for new vaccine development requires US$3.6 billion over ten years. The estimated total funding gap is US$1.5 billion.
Charts
Budget requirements for the Working Group on New TB Vaccines, 2006-2015 [.pdf]
